Scott Bird, DPM
Foot & Ankle Surgery · Boise, IDNPI 1992200331
Payments from drug & device makers
What this record shows
17 manufacturers reported payments, led by Impactortho, Inc. at 36.2% of the total. Reporting peaked in 2021 at $1,377 and has fallen 74.5% since, to $350 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in ID, where the typical reported total is $3,361.
Across 55 payments — averaging $60.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Impactortho, Inc.$1K
- Stryker$918
- Sportstek Medical, Inc$436
- Medline Industries LP$140
- Sawtooth Surgical Solutions Inc$119
- Polynovo North America LLC$116
- plus $385 from 11 others
What the payments were for
- Food & beverage$1,67851%
- Education$1,63649%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Impactortho, Inc. | 1 | $1,200 |
| Stryker | 28 | $918 |
| Sportstek Medical, Inc | 1 | $436 |
| Medline Industries LP | 1 | $140 |
| Sawtooth Surgical Solutions Inc | 3 | $119 |
| Polynovo North America LLC | 3 | $116 |
| Treace Medical Concepts, Inc. | 3 | $75 |
| Kerecis Limited | 3 | $63 |
| Midsouth Orthopedics Inc. | 1 | $47 |
| Alfasigma USA, Inc. | 2 | $33 |
| AstraZeneca | 2 | $30 |
| Amgen | 1 | $27 |
| Johnson & Johnson | 2 | $27 |
| KCI USA, Inc. | 1 | $25 |
| DJO, LLC | 1 | $23 |
| GRT US Holding, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$3,314 in reported general payments places this provider in the 45th percentile of 49 foot & ankle surgery providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 25 | $583 |
| Mupirocin | 26 | $264 |
| Terbinafine Hcl | 19 | $235 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $91 |
| Cephalexin | 15 | $90 |
| Methylprednisolone | 12 | $77 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $74 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Boise
- Kaitlin NearyBoise$867K
- Steven RoserBoise$102K
- Ryan KempBoise$8K
- Travis KempBoise$7K
- David ZarkouBoise$6K
- Christopher DesutterBoise$4K
- Boyd AndrewsBoise$2K
- Robert SwensenBoise$781
- Dan RobinsonBlackfoot$170K
- Kurt KinghornMeridian$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.